Reuters - Health Report

Click to View in Browser

Tuesday, November 14, 2017

Risks ahead for U.S. tax push as disputes linger, Trump returns

WASHINGTON (Reuters) - Congressional Republicans pushed ahead on Monday on a U.S. tax code overhaul as a Senate panel considered the issue, but risks lay ahead with major intraparty disputes unsettled and President Donald Trump returning soon from Asia as the debate heats up.

Janssen drops U.S. lawsuit against Samsung Bioepis' Remicade copy

SEOUL (Reuters) - A unit of healthcare conglomerate Johnson & Johnson has dropped a lawsuit it filed to block a copy of its rheumatoid arthritis drug Remicade produced by South Korea's Samsung Bioepis Co Ltd from being sold in the United States.

Sandoz says new clinical data support two biosimilars

ZURICH (Reuters) - Novartis' generics division, Sandoz, said new immunology data from four clinical studies supported its proposed biosimilars adalimumab for treating psoriasis and cancer drug rituximab.

U.S. approves digital pill that tracks when patients take it

(Reuters) - U.S. regulators have approved the first digital pill with an embedded sensor to track if patients are taking their medication properly, marking a significant step forward in the convergence of healthcare and technology.

U.S. top court to hear fight over California pregnancy center law

WASHINGTON (Reuters) - The U.S. Supreme Court on Monday agreed to decide whether a California law requiring private facilities that counsel pregnant women against abortion to post signs telling clients how to get state-funded abortions and contraceptives violates free speech rights.

Trump taps ex-pharma executive Azar as U.S. health secretary

WASHINGTON (Reuters) - President Donald Trump on Monday said he is nominating former pharmaceutical executive and industry lobbyist Alex Azar to serve as U.S. Health and Human Services secretary, saying Azar would push to lower the price of medicines.

New blood pressure range means half of Americans have hypertension

(Reuters) - Tighter blood pressure guidelines from U.S. heart organizations mean millions more people need to make lifestyle changes, or start taking medication, in order to avoid cardiovascular problems.

Cost of diabetes epidemic reaches $850 billion a year

(Reuters) - The number of people living with diabetes has tripled since 2000, pushing the global cost of the disease to $850 billion a year, medical experts said on Tuesday.

Chipotle denies link to 'Supergirl' actor's illness

(Reuters) - Chipotle Mexican Grill Inc on Monday denied allegations by actor Jeremy Jordan that eating at one of its restaurants landed him in the hospital.

New tool could let patients contribute to doctors' notes

(Reuters Health) - In theory, patients might be more engaged with their care and better able to inform doctors about any health issues if they could directly contribute to their own electronic medical records, a small U.S. study suggests.